| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.3 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |